Skip to content
Open access

EP145 - ECE_2148 - Histopathological diagnosis of surgically treated indeterminate adrenal masses

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

Indeterminate adrenal masses represent a diagnostic challenge, encompassing a broad spectrum of benign and malignant conditions, and significant overlap exists between benign and malignant lesions, including FDG-PET uptake.

Abstract

Adrenal incidentalomas are increasingly detected due to widespread use of advanced imaging modalities. Imaging evaluation plays a central role in assessing the risk of malignancy, with homogeneous, lipid-rich lesions (<10 Hounsfield units [HU] on unenhanced CT) considered benign. However, a substantial proportion of adrenal masses do not meet these criteria and are classified as indeterminate. Indeterminate adrenal masses are incidentally discovered lesions lacking definitive imaging or biochemical features of benignity or malignancy. While many are ultimately benign—most commonly lipid-poor adrenocortical adenomas—the differential diagnosis includes adrenocortical carcinoma and other rare malignant entities, posing a significant diagnostic challenge. To report histopathological diagnoses of surgically treated indeterminate adrenal masses and assess their relationship with preoperative imaging characteristics, including CT in all patients and MRI and/or FDG-PET, where available. We retrospectively identified patients who underwent adrenalectomy for indeterminate masses between 2022 and 2025. Patients with lesions showing clear features of malignancy (metastases, compatible biochemical findings, or known extra-adrenal primary malignancy) or diagnostic biochemical evidence of pheochromocytoma were excluded. Collected data included demographics, hormonal activity, imaging features and histopathological diagnosis. 32 patients were included (mean age 60.5 ± 12.4 years). Mean tumor size was 5.9 ± 3.2 cm (range 2.4-17 cm), with a mean unenhanced CT attenuation of 26.5 ± 9.7 HU. FDG-PET was available in 19 patients, with a mean SUVmax of 4.6 ± 2.0. Twenty patients (63%) had benign lesions: 16 lipid-poor adrenocortical adenomas, one black adenoma, one adrenal oncocytoma, two ganglioneuromas. Three patients had adrenocortical oncocytic neoplasms of uncertain malignant potential. Nine patients (28%) had malignant lesions: five adrenocortical carcinomas and four non-adrenocortical malignancies (metastasis, angiosarcoma, lymphoma, liposarcoma). Regarding hormonal activity, 12 patients exhibited mild autonomous cortisol secretion. Tumor size (5.4 vs 5.9 cm), unenhanced CT attenuation (26.4 vs 29.5 HU), and SUVmax (4.7 vs 6.7) did not differ significantly between benign and malignant lesions. Notably, no malignant lesion had unenhanced CT attenuation <20 HU, whereas five benign lesions and one of uncertain malignant potential did. Indeterminate adrenal masses represent a diagnostic challenge, encompassing a broad spectrum of benign and malignant conditions. Although additional imaging modalities may aid risk stratification, no single technique reliably establishes a definitive diagnosis, and significant overlap exists between benign and malignant lesions, including FDG-PET uptake. Consequently, final diagnosis often remains dependent on histopathological evaluation following surgery, underscoring the need for individualized, multidisciplinary diagnostic approach.

Read PDF

Similar papers

Review Aug 2026

Incidentally detected prevascular mediastinal nodules: An integrated review of imaging, clinical, and epidemiologic features.

Prevascular mediastinal lesions encompass a broad spectrum of entities, ranging from benign cysts to malignant tumors such as thymic epithelial tumors (TETs), lymphoma, and germ cell tumors (GCTs). With the increasing use of computed tomography (CT), incidentally detected, asymptomatic prevascular mediastinal nodules a...

Y. Ozawa, D. Takenaka, Takatoshi Aoki et al. · 0 citations
Open access Sep 2026

Histopathological Spectrum of Benign and Malignant Non-thyroid Neck Masses in Adults

Background: Neck masses in adults not related to the thyroid can have various benign and malignant origins, frequently posing diagnostic difficulties. Although FNAC is valuable for preliminary assessment, histopathology is considered the gold standard for conclusive diagnosis, aided by imaging and additional tests. The...

R. Anwar, Md Ashraful Islam, Md Mahbobul Haque et al. · 0 citations
Open access Sep 2026

Cystic Renal Masses: From Malignancy Probability to Risk-Adapted Management

Cystic renal masses (CRMs) encompass a broad spectrum of conditions ranging from simple renal cysts to cystic renal cell carcinoma. Their detection has increased markedly with the widespread use of abdominal imaging, raising concern about potential overtreatment: many complex CRMs treated surgically are ultimately beni...

Chen-Can Fang, Chen-Yi Ge, Li-Juan Yin et al. · 0 citations
Open access Oct 2026

Atypical ovarian fibroma and thecoma mimicking malignancy: clue for differentiation from malignant solid tumors.

PURPOSE To evaluate the characteristic findings of ovarian fibroma and thecoma (FT) with atypical magnetic resonance imaging (MRI) findings that mimic malignancy and to validate the improvement in diagnostic performance in differentiating between FTs and malignant solid tumors. MATERIALS AND METHODS This retrospectiv...

T. Aonuma, Ayumi Ohya, Daiya Takekoshi et al. · 0 citations
Case report Open access Aug 2026

Multimodality evaluation of bilateral parotid oncocytomas: A rare case report and literature review

Oncocytoma of the parotid gland is a rare benign salivary gland neoplasm, accounting for less than 2% of all salivary tumors. Bilateral parotid oncocytoma is an exceedingly rare entity that can mimic other salivary gland neoplasms on imaging. We report the case of a 72-year-old woman who underwent 18F-fluorodeoxyglucos...

S. Anwar, F. Mubarak, Amal Mahmood et al. · 0 citations
Sep 2026

Multimodal Imaging for Adrenal Tumor Characterization: Clinical Impact of the 2023 European Guidelines - A Single-Center Retrospective Study.

The 2023 guidelines may substantially reduce unnecessary adrenalectomies for benign lesions, and the risk of missing malignant tumors remains low when hormonal evaluation and multimodal imaging are used, particularly in indeterminate cases.

E. Lutz, T. Zaragori, C. Nominé-Criqui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.